nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—ALB—Irinotecan—colon cancer	0.313	0.402	CbGbCtD
Sodium lauryl sulfate—ALB—Fluorouracil—colon cancer	0.301	0.386	CbGbCtD
Sodium lauryl sulfate—ALB—Methotrexate—colon cancer	0.166	0.213	CbGbCtD
Sodium lauryl sulfate—Bronchopneumonia—Capecitabine—colon cancer	0.00738	0.0335	CcSEcCtD
Sodium lauryl sulfate—Intestinal perforation—Irinotecan—colon cancer	0.00609	0.0276	CcSEcCtD
Sodium lauryl sulfate—Intestinal obstruction—Vincristine—colon cancer	0.00363	0.0165	CcSEcCtD
Sodium lauryl sulfate—Intestinal obstruction—Irinotecan—colon cancer	0.00353	0.016	CcSEcCtD
Sodium lauryl sulfate—Swelling face—Capecitabine—colon cancer	0.00338	0.0154	CcSEcCtD
Sodium lauryl sulfate—Intestinal perforation—Methotrexate—colon cancer	0.00303	0.0138	CcSEcCtD
Sodium lauryl sulfate—Venous thrombosis—Capecitabine—colon cancer	0.00298	0.0135	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Fluorouracil—colon cancer	0.00294	0.0133	CcSEcCtD
Sodium lauryl sulfate—Tingling sensation—Fluorouracil—colon cancer	0.00287	0.013	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Vincristine—colon cancer	0.00283	0.0129	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Irinotecan—colon cancer	0.00276	0.0125	CcSEcCtD
Sodium lauryl sulfate—Tenderness—Fluorouracil—colon cancer	0.00264	0.012	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Fluorouracil—colon cancer	0.00264	0.012	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Irinotecan—colon cancer	0.00254	0.0116	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Fluorouracil—colon cancer	0.00253	0.0115	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Fluorouracil—colon cancer	0.00244	0.0111	CcSEcCtD
Sodium lauryl sulfate—Intestinal obstruction—Capecitabine—colon cancer	0.00236	0.0107	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Irinotecan—colon cancer	0.00209	0.00948	CcSEcCtD
Sodium lauryl sulfate—Coagulopathy—Capecitabine—colon cancer	0.00207	0.00939	CcSEcCtD
Sodium lauryl sulfate—Tingling sensation—Capecitabine—colon cancer	0.002	0.0091	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Fluorouracil—colon cancer	0.002	0.00908	CcSEcCtD
Sodium lauryl sulfate—Swelling—Fluorouracil—colon cancer	0.0019	0.00861	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Irinotecan—colon cancer	0.00189	0.00859	CcSEcCtD
Sodium lauryl sulfate—Disorientation—Fluorouracil—colon cancer	0.00187	0.00849	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Irinotecan—colon cancer	0.00184	0.00833	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Irinotecan—colon cancer	0.00178	0.00809	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Capecitabine—colon cancer	0.00177	0.00804	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Capecitabine—colon cancer	0.00176	0.00799	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Capecitabine—colon cancer	0.0017	0.00773	CcSEcCtD
Sodium lauryl sulfate—Cyanosis—Methotrexate—colon cancer	0.00169	0.00769	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Vincristine—colon cancer	0.00167	0.00757	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Irinotecan—colon cancer	0.00164	0.00743	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Irinotecan—colon cancer	0.00162	0.00738	CcSEcCtD
Sodium lauryl sulfate—Irritability—Fluorouracil—colon cancer	0.0016	0.00725	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Irinotecan—colon cancer	0.00159	0.00722	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Capecitabine—colon cancer	0.00153	0.00694	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Methotrexate—colon cancer	0.00153	0.00694	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Irinotecan—colon cancer	0.00152	0.0069	CcSEcCtD
Sodium lauryl sulfate—Abscess—Methotrexate—colon cancer	0.00152	0.00688	CcSEcCtD
Sodium lauryl sulfate—Sweating increased—Irinotecan—colon cancer	0.00147	0.00668	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Fluorouracil—colon cancer	0.00145	0.00656	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Capecitabine—colon cancer	0.0014	0.00635	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Methotrexate—colon cancer	0.00137	0.00624	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Vincristine—colon cancer	0.00136	0.00619	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Capecitabine—colon cancer	0.00136	0.00616	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Vincristine—colon cancer	0.00136	0.00615	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Irinotecan—colon cancer	0.00133	0.00602	CcSEcCtD
Sodium lauryl sulfate—Swelling—Capecitabine—colon cancer	0.00133	0.00602	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Irinotecan—colon cancer	0.00132	0.00601	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Irinotecan—colon cancer	0.00132	0.00599	CcSEcCtD
Sodium lauryl sulfate—Oliguria—Methotrexate—colon cancer	0.0013	0.00591	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Fluorouracil—colon cancer	0.00127	0.00577	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Methotrexate—colon cancer	0.00127	0.00575	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Capecitabine—colon cancer	0.00127	0.00575	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Fluorouracil—colon cancer	0.00126	0.00574	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Vincristine—colon cancer	0.00123	0.00561	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Capecitabine—colon cancer	0.00123	0.00558	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Capecitabine—colon cancer	0.00119	0.00542	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Fluorouracil—colon cancer	0.00115	0.00523	CcSEcCtD
Sodium lauryl sulfate—Irritability—Capecitabine—colon cancer	0.00112	0.00507	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Capecitabine—colon cancer	0.0011	0.00497	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Capecitabine—colon cancer	0.00109	0.00494	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Irinotecan—colon cancer	0.00108	0.0049	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Capecitabine—colon cancer	0.00106	0.00483	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Methotrexate—colon cancer	0.00104	0.00472	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Irinotecan—colon cancer	0.00104	0.00471	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Fluorouracil—colon cancer	0.00103	0.00469	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Capecitabine—colon cancer	0.00102	0.00462	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Capecitabine—colon cancer	0.00101	0.00459	CcSEcCtD
Sodium lauryl sulfate—Bronchospasm—Capecitabine—colon cancer	0.000994	0.00451	CcSEcCtD
Sodium lauryl sulfate—Sweating increased—Capecitabine—colon cancer	0.000984	0.00447	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Capecitabine—colon cancer	0.000972	0.00441	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Fluorouracil—colon cancer	0.00095	0.00431	CcSEcCtD
Sodium lauryl sulfate—Syncope—Irinotecan—colon cancer	0.000944	0.00428	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Methotrexate—colon cancer	0.000943	0.00428	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Vincristine—colon cancer	0.000936	0.00425	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Irinotecan—colon cancer	0.000925	0.0042	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Capecitabine—colon cancer	0.000888	0.00403	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Methotrexate—colon cancer	0.000888	0.00403	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Capecitabine—colon cancer	0.000886	0.00402	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Capecitabine—colon cancer	0.000883	0.00401	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Vincristine—colon cancer	0.000882	0.004	CcSEcCtD
Sodium lauryl sulfate—Oedema—Vincristine—colon cancer	0.000882	0.004	CcSEcCtD
Sodium lauryl sulfate—Infection—Vincristine—colon cancer	0.000876	0.00398	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Fluorouracil—colon cancer	0.000873	0.00396	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Irinotecan—colon cancer	0.000859	0.0039	CcSEcCtD
Sodium lauryl sulfate—Oedema—Irinotecan—colon cancer	0.000859	0.0039	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Fluorouracil—colon cancer	0.000858	0.00389	CcSEcCtD
Sodium lauryl sulfate—Infection—Irinotecan—colon cancer	0.000853	0.00387	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Vincristine—colon cancer	0.000852	0.00387	CcSEcCtD
Sodium lauryl sulfate—Shock—Irinotecan—colon cancer	0.000845	0.00383	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Vincristine—colon cancer	0.00084	0.00382	CcSEcCtD
Sodium lauryl sulfate—Irritability—Methotrexate—colon cancer	0.000831	0.00377	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Irinotecan—colon cancer	0.00083	0.00377	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Vincristine—colon cancer	0.000824	0.00374	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Fluorouracil—colon cancer	0.000822	0.00373	CcSEcCtD
Sodium lauryl sulfate—Oedema—Fluorouracil—colon cancer	0.000822	0.00373	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Irinotecan—colon cancer	0.000818	0.00372	CcSEcCtD
Sodium lauryl sulfate—Infection—Fluorouracil—colon cancer	0.000817	0.00371	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Capecitabine—colon cancer	0.000805	0.00365	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Fluorouracil—colon cancer	0.000803	0.00364	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Irinotecan—colon cancer	0.000802	0.00364	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Vincristine—colon cancer	0.000792	0.00359	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Fluorouracil—colon cancer	0.000784	0.00356	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Irinotecan—colon cancer	0.000771	0.0035	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Fluorouracil—colon cancer	0.000768	0.00349	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Vincristine—colon cancer	0.000766	0.00348	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Irinotecan—colon cancer	0.000766	0.00348	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Vincristine—colon cancer	0.00076	0.00345	CcSEcCtD
Sodium lauryl sulfate—Constipation—Vincristine—colon cancer	0.000754	0.00342	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Irinotecan—colon cancer	0.000746	0.00339	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Irinotecan—colon cancer	0.00074	0.00336	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Fluorouracil—colon cancer	0.000738	0.00335	CcSEcCtD
Sodium lauryl sulfate—Constipation—Irinotecan—colon cancer	0.000734	0.00333	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Fluorouracil—colon cancer	0.000733	0.00333	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Capecitabine—colon cancer	0.000723	0.00328	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Vincristine—colon cancer	0.000721	0.00327	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Fluorouracil—colon cancer	0.000715	0.00325	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Irinotecan—colon cancer	0.000702	0.00319	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Vincristine—colon cancer	0.000697	0.00316	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Vincristine—colon cancer	0.000697	0.00316	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Capecitabine—colon cancer	0.000694	0.00315	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Capecitabine—colon cancer	0.00069	0.00313	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Irinotecan—colon cancer	0.000679	0.00308	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Irinotecan—colon cancer	0.000679	0.00308	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Capecitabine—colon cancer	0.000664	0.00301	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Methotrexate—colon cancer	0.000659	0.00299	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Fluorouracil—colon cancer	0.000653	0.00297	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Fluorouracil—colon cancer	0.00065	0.00295	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Vincristine—colon cancer	0.00065	0.00295	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Irinotecan—colon cancer	0.000633	0.00287	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Vincristine—colon cancer	0.000633	0.00287	CcSEcCtD
Sodium lauryl sulfate—Syncope—Capecitabine—colon cancer	0.000631	0.00287	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Capecitabine—colon cancer	0.000622	0.00282	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Capecitabine—colon cancer	0.000619	0.00281	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Irinotecan—colon cancer	0.000616	0.0028	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Fluorouracil—colon cancer	0.000606	0.00275	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Vincristine—colon cancer	0.000603	0.00274	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Capecitabine—colon cancer	0.000599	0.00272	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Capecitabine—colon cancer	0.000597	0.00271	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Irinotecan—colon cancer	0.000588	0.00267	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Vincristine—colon cancer	0.000583	0.00265	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Fluorouracil—colon cancer	0.000582	0.00264	CcSEcCtD
Sodium lauryl sulfate—Oedema—Capecitabine—colon cancer	0.000575	0.00261	CcSEcCtD
Sodium lauryl sulfate—Infection—Capecitabine—colon cancer	0.000571	0.00259	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Irinotecan—colon cancer	0.000568	0.00258	CcSEcCtD
Sodium lauryl sulfate—Shock—Capecitabine—colon cancer	0.000565	0.00257	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Fluorouracil—colon cancer	0.000563	0.00255	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Capecitabine—colon cancer	0.000561	0.00255	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vincristine—colon cancer	0.000561	0.00254	CcSEcCtD
Sodium lauryl sulfate—Rash—Vincristine—colon cancer	0.000556	0.00252	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Capecitabine—colon cancer	0.000556	0.00252	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Vincristine—colon cancer	0.000555	0.00252	CcSEcCtD
Sodium lauryl sulfate—Headache—Vincristine—colon cancer	0.000552	0.00251	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Capecitabine—colon cancer	0.000548	0.00249	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Irinotecan—colon cancer	0.000546	0.00248	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Fluorouracil—colon cancer	0.000544	0.00247	CcSEcCtD
Sodium lauryl sulfate—Rash—Irinotecan—colon cancer	0.000541	0.00246	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Irinotecan—colon cancer	0.000541	0.00246	CcSEcCtD
Sodium lauryl sulfate—Headache—Irinotecan—colon cancer	0.000538	0.00244	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Capecitabine—colon cancer	0.000537	0.00244	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vincristine—colon cancer	0.000524	0.00238	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Fluorouracil—colon cancer	0.000523	0.00237	CcSEcCtD
Sodium lauryl sulfate—Rash—Fluorouracil—colon cancer	0.000519	0.00235	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Fluorouracil—colon cancer	0.000518	0.00235	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Capecitabine—colon cancer	0.000516	0.00234	CcSEcCtD
Sodium lauryl sulfate—Headache—Fluorouracil—colon cancer	0.000515	0.00234	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Methotrexate—colon cancer	0.000513	0.00233	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Capecitabine—colon cancer	0.000512	0.00233	CcSEcCtD
Sodium lauryl sulfate—Nausea—Irinotecan—colon cancer	0.00051	0.00232	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Capecitabine—colon cancer	0.0005	0.00227	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Capecitabine—colon cancer	0.000495	0.00225	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Methotrexate—colon cancer	0.000494	0.00224	CcSEcCtD
Sodium lauryl sulfate—Constipation—Capecitabine—colon cancer	0.000491	0.00223	CcSEcCtD
Sodium lauryl sulfate—Nausea—Fluorouracil—colon cancer	0.000488	0.00222	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Capecitabine—colon cancer	0.00047	0.00213	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Capecitabine—colon cancer	0.000457	0.00207	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Capecitabine—colon cancer	0.000454	0.00206	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Capecitabine—colon cancer	0.000454	0.00206	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Methotrexate—colon cancer	0.000454	0.00206	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Methotrexate—colon cancer	0.000446	0.00203	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Methotrexate—colon cancer	0.000428	0.00194	CcSEcCtD
Sodium lauryl sulfate—Infection—Methotrexate—colon cancer	0.000425	0.00193	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Capecitabine—colon cancer	0.000423	0.00192	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Methotrexate—colon cancer	0.000414	0.00188	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Capecitabine—colon cancer	0.000412	0.00187	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Methotrexate—colon cancer	0.000408	0.00185	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Capecitabine—colon cancer	0.000407	0.00185	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Methotrexate—colon cancer	0.0004	0.00181	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Capecitabine—colon cancer	0.000393	0.00178	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Methotrexate—colon cancer	0.000384	0.00174	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Methotrexate—colon cancer	0.000381	0.00173	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Capecitabine—colon cancer	0.00038	0.00173	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Methotrexate—colon cancer	0.000372	0.00169	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Methotrexate—colon cancer	0.000369	0.00167	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Capecitabine—colon cancer	0.000365	0.00166	CcSEcCtD
Sodium lauryl sulfate—Rash—Capecitabine—colon cancer	0.000362	0.00164	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Capecitabine—colon cancer	0.000362	0.00164	CcSEcCtD
Sodium lauryl sulfate—Headache—Capecitabine—colon cancer	0.00036	0.00163	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Methotrexate—colon cancer	0.00035	0.00159	CcSEcCtD
Sodium lauryl sulfate—Nausea—Capecitabine—colon cancer	0.000341	0.00155	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Methotrexate—colon cancer	0.00034	0.00154	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Methotrexate—colon cancer	0.000338	0.00154	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Methotrexate—colon cancer	0.000338	0.00154	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Methotrexate—colon cancer	0.000315	0.00143	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Methotrexate—colon cancer	0.000307	0.00139	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Methotrexate—colon cancer	0.000303	0.00137	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Methotrexate—colon cancer	0.000293	0.00133	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Methotrexate—colon cancer	0.000283	0.00128	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Methotrexate—colon cancer	0.000272	0.00123	CcSEcCtD
Sodium lauryl sulfate—Rash—Methotrexate—colon cancer	0.00027	0.00122	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Methotrexate—colon cancer	0.000269	0.00122	CcSEcCtD
Sodium lauryl sulfate—Headache—Methotrexate—colon cancer	0.000268	0.00122	CcSEcCtD
Sodium lauryl sulfate—Nausea—Methotrexate—colon cancer	0.000254	0.00115	CcSEcCtD
